These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 16736756

  • 21. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD, Chang CC, Thamm DH, Kraft SL, Harmon JF, Vogt AP, Sumerlin BS, Boyes SG.
    Langmuir; 2009 Aug 18; 25(16):9487-99. PubMed ID: 19422256
    [Abstract] [Full Text] [Related]

  • 22. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration.
    Ghaghada K, Hawley C, Kawaji K, Annapragada A, Mukundan S.
    Acad Radiol; 2008 Oct 18; 15(10):1259-63. PubMed ID: 18790397
    [Abstract] [Full Text] [Related]

  • 23. Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.
    Zhang L, Liu Y, Yu D, Zhangl N.
    J Biomed Nanotechnol; 2013 May 18; 9(5):863-9. PubMed ID: 23802417
    [Abstract] [Full Text] [Related]

  • 24. Development of Gd(III) porphyrin-conjugated chitosan nanoparticles as contrast agents for magnetic resonance imaging.
    Jahanbin T, Sauriat-Dorizon H, Spearman P, Benderbous S, Korri-Youssoufi H.
    Mater Sci Eng C Mater Biol Appl; 2015 May 18; 52():325-32. PubMed ID: 25953574
    [Abstract] [Full Text] [Related]

  • 25. Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast Agent.
    Lohrke J, Berger M, Frenzel T, Hilger CS, Jost G, Panknin O, Bauser M, Ebert W, Pietsch H.
    Invest Radiol; 2022 Oct 01; 57(10):629-638. PubMed ID: 35703267
    [Abstract] [Full Text] [Related]

  • 26. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles.
    Xu K, Liu H, Zhang J, Tong H, Zhao Z, Zhang W.
    Int J Nanomedicine; 2019 Oct 01; 14():7879-7889. PubMed ID: 31576129
    [Abstract] [Full Text] [Related]

  • 27. Thermodynamic stability and kinetic inertness of a Gd-DTPA bisamide complex grafted onto gold nanoparticles.
    Mogilireddy V, Déchamps-Olivier I, Alric C, Laurent G, Laurent S, Vander Elst L, Muller R, Bazzi R, Roux S, Tillement O, Chuburu F.
    Contrast Media Mol Imaging; 2015 Oct 01; 10(3):179-87. PubMed ID: 25130910
    [Abstract] [Full Text] [Related]

  • 28. The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging.
    Sarka L, Burai L, Brücher E.
    Chemistry; 2000 Feb 18; 6(4):719-24. PubMed ID: 10807182
    [Abstract] [Full Text] [Related]

  • 29. Enhancing T1 magnetic resonance imaging contrast with internalized gadolinium(III) in a multilayer nanoparticle.
    Marangoni VS, Neumann O, Henderson L, Kaffes CC, Zhang H, Zhang R, Bishnoi S, Ayala-Orozco C, Zucolotto V, Bankson JA, Nordlander P, Halas NJ.
    Proc Natl Acad Sci U S A; 2017 Jul 03; 114(27):6960-6965. PubMed ID: 28630340
    [Abstract] [Full Text] [Related]

  • 30. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
    Du H, Yu J, Guo D, Yang W, Wang J, Zhang B.
    Langmuir; 2016 Feb 02; 32(4):1155-65. PubMed ID: 26740341
    [Abstract] [Full Text] [Related]

  • 31. Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging.
    Vivero-Escoto JL, Rieter WJ, Lau H, Huxford-Phillips RC, Lin W.
    Small; 2013 Oct 25; 9(20):3523-31. PubMed ID: 23613450
    [Abstract] [Full Text] [Related]

  • 32. Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid.
    Anderson EA, Isaacman S, Peabody DS, Wang EY, Canary JW, Kirshenbaum K.
    Nano Lett; 2006 Jun 25; 6(6):1160-4. PubMed ID: 16771573
    [Abstract] [Full Text] [Related]

  • 33. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
    Ghaghada KB, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A.
    PLoS One; 2009 Oct 29; 4(10):e7628. PubMed ID: 19893616
    [Abstract] [Full Text] [Related]

  • 34. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S.
    Biomaterials; 2011 Jul 29; 32(20):4584-93. PubMed ID: 21458063
    [Abstract] [Full Text] [Related]

  • 35. High proton relaxivity for gadolinium oxide nanoparticles.
    Engström M, Klasson A, Pedersen H, Vahlberg C, Käll PO, Uvdal K.
    MAGMA; 2006 Sep 29; 19(4):180-6. PubMed ID: 16909260
    [Abstract] [Full Text] [Related]

  • 36. Colloidal amphiphile self-assembly particles composed of gadolinium oleate and myverol: evaluation as contrast agents for magnetic resonance imaging.
    Liu G, Conn CE, Waddington LJ, Mudie ST, Drummond CJ.
    Langmuir; 2010 Feb 16; 26(4):2383-91. PubMed ID: 19852474
    [Abstract] [Full Text] [Related]

  • 37. Effective tracking of bone mesenchymal stem cells in vivo by magnetic resonance imaging using melanin-based gadolinium3+ nanoparticles.
    Cai WW, Wang LJ, Li SJ, Zhang XP, Li TT, Wang YH, Yang X, Xie J, Li JD, Liu SJ, Xu W, He S, Cheng Z, Fan QL, Zhang RP.
    J Biomed Mater Res A; 2017 Jan 16; 105(1):131-137. PubMed ID: 27588709
    [Abstract] [Full Text] [Related]

  • 38. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY, Baek MJ, Choi ES, Woo S, Kim JH, Kim TJ, Jung JC, Chae KS, Chang Y, Lee GH.
    ACS Nano; 2009 Nov 24; 3(11):3663-9. PubMed ID: 19835389
    [Abstract] [Full Text] [Related]

  • 39. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P.
    Acc Chem Res; 2009 Jul 21; 42(7):851-62. PubMed ID: 19222207
    [Abstract] [Full Text] [Related]

  • 40. Preparation and Evaluation of Multiple Nanoemulsions Containing Gadolinium (III) Chelate as a Potential Magnetic Resonance Imaging (MRI) Contrast Agent.
    Sigward E, Corvis Y, Doan BT, Kindsiko K, Seguin J, Scherman D, Brossard D, Mignet N, Espeau P, Crauste-Manciet S.
    Pharm Res; 2015 Sep 21; 32(9):2983-94. PubMed ID: 25805598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.